Abstract

MODERN VALIDATED ANALYTICAL METHODS FOR ESTIMATION OF TENELIGLIPTIN AND REMOGLIFLOZIN ETABONATE: A REVIEW.

Chhayaben Shah*, Yesha Shah, Saiyam Vora and Jemil Lathigara

ABSTRACT

Diabetes is a condition in which a patient has a high blood sugar level. In India, diabetic patients are mostly seen, and many classes of anti-diabetic agents are available. Analytical methods are crucial since they offer improvements and other alternatives. This review mainly focuses on developed validated analytical methods for the estimation of sodium-glucose co-transporter 2 inhibitor-Remogliflozin etabonate and dipeptidyl peptidase-4 inhibitor- Teneligliptin. This study may serve as an overview and categorization of the numerous analytical methods those are mostly employed to identify Remogliflozin etabonate and Teneligliptin in bulk and different formulations. Analytical methods are crucial since they offer improvements and other alternatives. So, this scrutinization can be helpful for the development of new analytical methods for the estimation of Remogliflozin etabonate andTeneligliptin individually or simultaneously with other drug combinations.

Keywords: Analytical method, Teneligliptin, Remogliflozin etabonate.